AMPs were first discovered for their antimicrobial and membrane-permeating activity, but some highly cationic AMPs such as cathelicidin LL-37 have been shown to be potently proinflammatory in lupus and rheumatoid arthritis, as well as in autoimmune skin diseases such as psoriasis and rosacea. This evidence concerns the gene CAMP and systemic lupus erythematosus.